Blog – Why “Normal” Cognition Is Hindering Preclinical Alzheimer’s Trials
“Normal” cognition may be masking treatment effects in Alzheimer’s trials. Andrew Kiselica explores how subtle decline could change everything.
All posts by Dementia Researcher
Profile – Franziska Weinmar, University of Tübingen
Franziska Weinmar is a PhD researcher at University of Tübingen studying how hormones shape women’s mental health, and hosts the Let’s Talk About Women podcast.
Profile – Dr Andrew Kiselica, University of Georgia
Dr Andrew Kiselica is an Associate Professor at the University of Georgia studying early Alzheimer’s detection, rural screening and dementia risk.
Blog – How Site Initiation Visits work and why they matter
Jacqui Kerr explains how Site Initiation Visits prepare research teams, ensure compliance, and set the foundation for safe, high quality clinical trials.
Profile – Professor Vibe G. Frokjaer, University of Copenhagen
Professor Vibe G Frokjaer, Clinical Professor at University of Copenhagen, studies brain architecture of mood disorder risk to improve prevention and treatment.
Parkinson’s Research Gaps Exposed
New report finds Parkinson’s research overlooks prevention and care. Explore where funding goes, what is missing, and why it matters.
Profile – Kirsty Hynes, Neuroprogressive and Dementia Network
Kirsty Hynes is a Clinical Studies Officer at ENRICH Scotland supporting care home research, with a background in mental health nursing and a love of running.
Podcast – ADPD 2026 Conference Highlights – Part Two
AD/PD 2026 reflections continue with new insights on biomarkers, personalised medicine, and future treatments shaping dementia research.
Podcast – ADPD 2026 Conference Highlights – Part One
Conference highlights from AD/PD 2026 in Copenhagen, exploring biomarkers, AI, co pathology, and future treatments in dementia research.
MND Association: Rethinking Grief Support
Webinar from the MND Association explores a new digital grief triage tool, asking when support is needed and how to guide people to the right help.
Profile – Dr Marieta Vassileva, UCL ARUK Drug Discovery Institute
Dr Marieta Vassileva is a Research Fellow at UCL ARUK Drug Discovery Institute studying microglia in neurodegeneration to develop new dementia therapies.
Profile – Dr Sofie Let Frandsen, Vesper Bio
Dr Sofie Let Frandsen is a Senior Research Scientist at Vesper Bio studying neurodegeneration, with a focus on FTD GRN and a passion for preclinical research.